Health-related quality of life in children and adolescents living with Gaucher disease and their parents

References

• Baldellou, A., Andria, G., Campbell, P. E., Charrow, J., Cohen, I. J., Grabowski, G. A., … Vellodi, A. (2004). Paediatric non-neuronopathic Gaucher disease: Recommendations for treatment and monitoring. European Journal of Pediatrics, 163(2), 67–75. doi: 10.1007/s00431-003-1363-z
   PubMed Web of Science ®Google Scholar
• Baldellou, A., Dalmau, J., & Sanjurjo, P. (2016). Recomendaciones para el diagnóstico y el tratamiento de la enfermedad de Gaucher durante la infancia [Recommendations for diagnosis and treatment of pediatric Gaucher disease]. Acta Pediátrica Española, 74(1), 4–15.
   Google Scholar
• Bugescu, N., Naylor, P. E., Hudson, K., Aoki, C. D., Cordova, M. J., & Packman, W. (2016). The psychosocial impact of Fabry disease on pediatric patients. Journal of Pediatric Genetics, 5(3), 141–149. doi:10.1055/s-0036-1584357
   PubMed Web of Science ®Google Scholar
• Capablo, J. L., Saenz de Cabezón, A., Fraile, J., Alfonso, P., Pocovi, M., Giraldo, P., & Spanish Group on Gaucher Disease. (2008). Neurological evaluation of patients with Gaucher disease diagnosed as type 1. Journal of Neurology, Neurosurgery & Psychiatry, 79(2), 219–222. doi: 10.1136/jnnp.2006.111518
   PubMed Web of Science ®Google Scholar
• Cohen, J. S., & Biesecker, B. B. (2010). Quality of life in rare genetic conditions: A systematic review of the literature. American Journal of Medical Genetics Part A, 152A(5), 1136–1156. doi:10.1002/ajmg.a.33380
   PubMed Web of Science ®Google Scholar
• Damiano, A. M., Pastores, G. M., & Ware, J. E., Jr. (1998). The health-related quality of life of adults with Gaucher’s disease receiving enzyme replacement therapy: Results from a retrospective study. Quality of Life Research, 7(5), 373–386. doi: 10.1023/A:1008814105603
   PubMed Web of Science ®Google Scholar
• Deroma, L., Sechi, A., Dardis, A., Macor, D., Liva, G., Ciana, G., & Bembi, B. (2013). Did the temporary shortage in supply of imiglucerase have clinical consequences? Retrospective observational study on 34 Italian Gaucher type I patients. JIMD Reports, 7, 117–122. doi:10.1007/8904_2012_158
   PubMedGoogle Scholar
• Eiser, C., & Varni, J. W. (2013). Health-related quality of life and symptom reporting: Similarities and differences between children and their parents. European Journal of Pediatrics, 172(10), 1299–1304. doi:10.1007/s00431-013-2049-9
   PubMed Web of Science ®Google Scholar
• Erikson, A., Karlberg, J., Skogman, A. L., & Dreborg, S. (1987). Gaucher disease (type III): Intellectual profile. Pediatric Neurology, 3(2), 87–91. doi: 10.1016/0887-8994(87)90033-6
   PubMed Web of Science ®Google Scholar
• Giraldo, P., Pérez-López, J., Núñez, R., Fernández-delaPuebla, R., Luño, E., Saura-Grau, S., … Serna, J. (2016). Patients with type 1 Gaucher disease in Spain: A cross-sectional evaluation of health status. Blood Cells, Molecules, and Diseases, 56, 23–30. doi:10.1016/j.bcmd.2015.10.001
   PubMed Web of Science ®Google Scholar
• Giraldo, P., Pocoví, M., Pérez-Calvo, J., Rubio-Félix, D., & Giralt, M. (2000). Report of the Spanish Gaucher’s disease registry: Clinical and genetic characteristics. Haematologica, 85(8), 792–799.
   PubMed Web of Science ®Google Scholar
• Giraldo, P., Solano, V., Pérez-Calvo, J. I., Giralt, M., Rubio-Félix, R., & Spanish Group on Gaucher Disease. (2005). Quality of life related to type 1 Gaucher disease: Spanish experience. Quality of Life Research, 14, 453–461. doi: 10.1007/s11136-004-0794-y
   PubMed Web of Science ®Google Scholar
• Goker-Alpan, O., Wiggs, E. A., Eblan, M. J., Benko, W., Ziegler, S. G., Sidransky, E., & Schiffmann, R. (2008). Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease. The Journal of Pediatrics, 153(1), 89–94. doi:10.1016/j.jpeds.2007.12.023
   PubMed Web of Science ®Google Scholar
• González-Gil, T., Mendoza-Soto, A., Alonso-Lloret, F., Castro-Murga, R., Pose-Becerra, C., & Martín-Arribas, M. C. (2012). The Spanish version of the health-related quality of life questionnaire for children and adolescents with heart disease (PedsQLTM). Revista Española de Cardiologia (English Edition), 65(3), 249–257. doi:10.1016/j.recesp.2011.10.010
   PubMed Web of Science ®Google Scholar
• Grabowski, G. A., Andria, G., Baldellou, A., Campbell, P. E., Charrow, J., Cohen, I. J., … Vellodi, A. (2004). Pediatric non-neuronopathic Gaucher disease: Presentation, diagnosis and assessment. Consensus statements. European Journal of Pediatrics, 163(2), 58–66. doi: 10.1007/s00431-003-1362-0
   PubMed Web of Science ®Google Scholar
• Hayes, R. P., Grinzaid, K. A., Duffey, E. B., & Elsas, L. J. (1998). The impact of Gaucher disease and its treatment on quality of life. Quality of Life Research, 7(6), 521–534. doi: 10.1023/A:1008878425167
   PubMed Web of Science ®Google Scholar
• Masek, B. J., Sims, K. B., Bove, C. M., Korson, M. S., Short, P., & Norman, D. K. (1999). Quality of life assessment in adults with type 1 Gaucher disease. Quality of Life Research, 8(3), 263–268. doi: 10.1023/A:1008859420641
   PubMed Web of Science ®Google Scholar
• McCabe, E. B., Fine, B. A., & Golbus, M. S. (1996). Gaucher disease: Current issues in diagnosis and treatment. JAMA, 275(7), 548–553. doi:10.1001/jama.1996.03530310054033
   PubMed Web of Science ®Google Scholar
• Milligan, A., Hughes, D., Goodwin, S., Richfield, L., & Mehta, A. (2006). Intravenous enzyme replacement therapy: Better in home or hospital? British Journal of Nursing, 15(6), 330–333. doi: 10.12968/bjon.2006.15.6.20681
   PubMedGoogle Scholar
• Oliveira, F. L., Alegra, T., Dornelles, A., Krug, B. C., Netto, C. B., da Rocha, N. S., … Schwartz, I. V. (2013). Quality of life of Brazilian patients with Gaucher disease and Fabry disease. JIMD Reports, 7, 31–37. doi:10.1007/8904_2012_136
   PubMedGoogle Scholar
• Packman, W., Crosbie, T. W., Behnken, M., Eudy, K., & Packman, S. (2010). Living with Gaucher disease: Emotional health, psychosocial needs and concerns of individuals with Gaucher disease. American Journal of Medical Genetics Part A, 152A(8), 2002–2010. doi:10.1002/ajmg.a.33527
   PubMed Web of Science ®Google Scholar
• Packman, W., Wilson Crosbie, T., Riesner, A., Fairley, C., & Packman, S. (2006). Psychological complications of patients with Gaucher disease. Journal of Inherited Metabolic Disease, 29(1), 99–105. doi: 10.1007/s10545-006-0154-x
   PubMed Web of Science ®Google Scholar
• Pastores, G. M., Barnett, N. L., Bathan, P., & Kolodny, E. H. (2003). A neurological symptom survey of patients with type I Gaucher disease. Journal of Inherited Metabolic Disease, 26(7), 641–645. doi: 10.1023/B:BOLI.0000005623.60471.51
   PubMed Web of Science ®Google Scholar
• Remor, E. (2011). Predictors of treatment difficulties and satisfaction with Haemophilia therapy in adult patients. Haemophilia, 17(5), e901–e905. doi:10.1111/j.1365-2516.2011.02578.x
   PubMed Web of Science ®Google Scholar
• Rosenthal, R. (1991). Meta-analytic procedures for social research (revised). Newbury Park, CA: Sage.
   Google Scholar
• Salovey, P., Rothman, A. J., Detweiler, J. B., & Steward, W. T. (2000). Emotional states and physical health. American Psychologist, 55(1), 110–121. doi: 10.1037/0003-066X.55.1.110
   PubMed Web of Science ®Google Scholar
• Varni, J. W., Bendo, C. B., Nurko, S., Shulman, R. J., Self, M. M., Franciosi, J. P., … Pohl, J. F. (2015). Health-related quality of life in pediatric patients with functional and organic gastrointestinal diseases. The Journal of Pediatrics, 166(1), 85–90. doi: 10.1016/j.jpeds.2014.08.022
   PubMed Web of Science ®Google Scholar
• Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL™ 4.0: Reliability and validity of the pediatric quality of life inventory™ version 4.0 generic core scales in healthy and patient populations. Medical Care, 39, 800–812. doi: 10.1097/00005650-200108000-00006
   PubMed Web of Science ®Google Scholar
• Varni, J. W., Seid, M., & Rode, C. A. (1999). The PedsQL™: measurement model for the pediatric quality of life inventory. Medical Care, 37, 126–139. doi: 10.1097/00005650-199902000-00003
   PubMed Web of Science ®Google Scholar
• Weinreb, N., Barranger, J., Packman, S., Prakash-Cheng, A., Rosenbloom, B., Sims, K., … Pastores, G. M. (2007). Imiglucerase (cerezyme®) improves quality of life in patients with skeletal manifestations of gaucher disease. Clinical Genetics, 71(6), 576–588. doi: 10.1111/j.1399-0004.2007.00811.x
   PubMed Web of Science ®Google Scholar
• Zimran, A., Sorge, J., Gross, E., Kubitz, M., West, C., & Beutler, E. (1989). Prediction of severity of Gaucher’s disease by identification of mutations at DNA level. The Lancet, 334, 349–352. doi: 10.1016/S0140-6736(89)90536-9
   Google Scholar